Crowdonomics
Pure Culture Beauty

Reg CF · SAFE · May 2023

ClosedReached targetReg CFSAFE
via Republic · last checked Oct 8, 2026View campaign
Raised
$49.4K / $1.2M max
4% of ceiling · target hit day 39
Investors
38
$1.3K avg
Valuation cap
$7.5M
cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors
$44K$22K$0
27140
May 15, 2023 · openedJul 12, 2023 · last reading
Target ($25K) hit — Jun 23, 2023, day 39Deadline Jul 17, 2023 — 5 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via Republic, last checked Oct 8, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2021–FY2022 · hover for source
$41K
−$997K
FY2021
$250K
−$1.1M
FY2022
RevenueNet income
Metric
FY2021 reviewed
FY2022 reviewed
Income statement
Revenue
$40,908
$249,921
Cost of goods sold
$31,707
$121,825
Gross margin
22%
51%
Net income
-$997,397
-$1,073,780
Taxes paid
$0
$0
Balance sheet
Cash
$422,418
$215,545
Accounts receivable
$0
$13,733
Total assets
$1,092,914
$1,308,339
Short-term debt
$1,470,658
$1,725,496
Long-term debt
$0
$0
Total liabilities
$1,470,658
$1,725,496
Other
Headcount
—
4

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$7.5M
Conversion discount15%

Perks

Invest $1,000, receive 1 cusom skincare kit$1K+

Offering details

Target$25,000
Max$1,235,000
Min investment$200
OpenedMay 15, 2023
DeadlineJul 17, 2023
ClosedJul 17, 2023
Days active63

Links & provenance

Source: Manual
0001930002-23-000002
Last synced Aug 19, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.